Reckitt Benckiser Group (LON:RB)‘s stock had its “under review” rating reissued by investment analysts at Shore Capital in a research report issued to clients and investors on Wednesday, ThisIsMoney.Co.Uk reports.

A number of other equities analysts also recently weighed in on the stock. Barclays restated an “overweight” rating and set a GBX 7,500 ($98.00) target price on shares of Reckitt Benckiser Group in a report on Monday, April 15th. UBS Group restated a “neutral” rating and set a GBX 6,400 ($83.63) target price (up from GBX 6,300 ($82.32)) on shares of Reckitt Benckiser Group in a report on Monday, April 1st. JPMorgan Chase & Co. restated an “overweight” rating on shares of Reckitt Benckiser Group in a report on Monday, April 8th. Deutsche Bank set a GBX 8,000 ($104.53) target price on shares of Reckitt Benckiser Group and gave the stock a “buy” rating in a report on Thursday, April 11th. Finally, Liberum Capital restated a “buy” rating on shares of Reckitt Benckiser Group in a report on Wednesday, February 13th. Three equities research analysts have rated the stock with a sell rating, four have given a hold rating and eleven have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of GBX 7,154.12 ($93.48).

Shares of RB opened at GBX 6,314 ($82.50) on Wednesday. The firm has a market cap of $45.27 billion and a P/E ratio of 20.72. Reckitt Benckiser Group has a 1-year low of GBX 5,559 ($72.64) and a 1-year high of GBX 7,174 ($93.74). The company has a debt-to-equity ratio of 80.49, a quick ratio of 0.47 and a current ratio of 0.65.

In related news, insider Christopher Sinclair acquired 1,076 shares of Reckitt Benckiser Group stock in a transaction on Thursday, May 23rd. The stock was purchased at an average cost of GBX 6,375 ($83.30) per share, with a total value of £68,595 ($89,631.52). Also, insider Andrew R. J. Bonfield acquired 146 shares of Reckitt Benckiser Group stock in a transaction on Tuesday, May 21st. The shares were bought at an average cost of GBX 6,290 ($82.19) per share, with a total value of £9,183.40 ($11,999.74).

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

See Also: Asset Allocation Models, Which is Right For You?

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.